A novel CHD7 mutation in an adolescent presenting with growth and pubertal delay
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mutations in the CHD7 gene, encoding for the chromodomain helicase DNAbinding protein 7, are found in approximately 60% of individuals with CHARGE syndrome (coloboma, heart defects, choanal atresia, retarded growth and development, genital hypoplasia, ear abnormalities and/or hearing loss). Herein, we present a clinical case of a 14-year-old male presenting for evaluation of poor growth and pubertal delay highlighting the diagnostic challenges of CHARGE syndrome. The patient was born full term and underwent surgery at 5 days of life for bilateral choanal atresia. Developmental milestones were normally achieved. At age 14 his height and weight were -2.04 and -1.74 standard deviation score respectively. He had anosmia as well as prepubertal testes and micropenis (4 cm×1 cm). The biological profile showed low basal serum testosterone and gonadotropins (testosterone, 0.2 nmol/L; luteinizing hormone, 0.5 U/L; follicle-stimulating hormone, 1.3 U/L), and otherwise normal pituitary function and normal imaging of the hypothalamic-pituitary area. The constellation of choanal atresia, anosmia, mild dysmorphic features, micropenis and delayed puberty were suggestive of CHARGE syndrome. Targeted genetic testing of CHD7 was performed revealing a de novo heterozygous CHD7 mutation (c.4234T>G [p.Tyr1412Asp]). Further paraclinical investigations confirmed CHARGE syndrome. Despite the presence of suggestive features, CHARGE syndrome remained undiagnosed in this patient until adolescence. Genetic testing helps clarify the phenotypic and genotypic spectrum to facilitate diagnosis, thus promoting optimal follow-up, treatment, and appropriate genetic counselling.
Abstract
Mutations in the CHD7 gene, encoding for the chromodomain helicase DNAbinding protein 7, are found in approximately 60% of individuals with CHARGE syndrome (coloboma, heart defects, choanal atresia, retarded growth and development, genital hypoplasia, ear abnormalities and/or hearing loss). Herein, we present a clinical case of a 14-year-old male presenting for evaluation of poor growth and pubertal delay highlighting the diagnostic challenges of CHARGE syndrome. The patient was born full term and underwent surgery at 5 days of life for bilateral choanal atresia. Developmental milestones were normally achieved. At age 14 his height and weight were -2.04 and -1.74 standard deviation score respectively. He had anosmia as well as prepubertal testes and micropenis (4 cm×1 cm). The biological profile showed low basal serum testosterone and gonadotropins (testosterone, 0.2 nmol/L; luteinizing hormone, 0.5 U/L; follicle-stimulating hormone, 1.3 U/L), and otherwise normal pituitary function and normal imaging of the hypothalamic-pituitary area. The constellation of choanal atresia, anosmia, mild dysmorphic features, micropenis and delayed puberty were suggestive of CHARGE syndrome. Targeted genetic testing of CHD7 was performed revealing a de novo heterozygous CHD7 mutation (c.4234T>G [p.Tyr1412Asp]). Further paraclinical investigations confirmed CHARGE syndrome. Despite the presence of suggestive features, CHARGE syndrome remained undiagnosed in this patient until adolescence. Genetic testing helps clarify the phenotypic and genotypic spectrum to facilitate diagnosis, thus promoting optimal follow-up, treatment, and appropriate genetic counselling.
참고문헌 (20)
- Blake KD, "CHARGE syndrome", Orphanet J Rare Dis, 1, pp.34~ (2006)
- Bergman JE, "The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome", J Clin Endocrinol Metab, 97, pp.E858~E862 (2012)
- Verloes A, "Updated diagnostic criteria for CHARGE syndrome: a proposal", Am J Med Genet A, 133A, pp.306~308 (2005)
- Jongmans MC, "CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene", J Med Genet, 43, pp.306~314 (2006)
- Conny MA van Ravenswaaij-Arts, "Clinical utility gene card for: CHARGE syndrome - update 2015", European Journal of Human Genetics, 23(11), pp.3~4 (2015), Springer Science and Business Media LLC[DOI]
- Basson MA, "Functional insights into chromatin remodelling from studies on CHARGE syndrome", Trends Genet, 31, pp.600~611 (2015)
- Bergman JE, "CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype", J Med Genet, 48, pp.334~342 (2011)
- Hall JG, "Handbook of normal physical measurements" (1989), Oxford Medical Publications
- Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Kobayashi Y, "Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation", Genome Med, 9, pp.13~ (2017)
- Sinha V, "Choanal atresia: surgical management by Hegar's dilators", Indian J Otolaryngol Head Neck Surg, 66, pp.272~275 (2014)
- Burrow TA, "Characterization of congenital anomalies in individuals with choanal atresia", Arch Otolaryngol Head Neck Surg, 135, pp.543~547 (2009)
- Kim H, "Clinical features and surgical outcomes of congenital choanal atresia: factors influencing success from 20-year review in an institute", Am J Otolaryngol, 33, pp.308~312 (2012)
- Hale CL, "Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria", Am J Med Genet A, 170A, pp.344~354 (2016)
- Dwyer AA, "Management of endocrine disease: reversible hypogonadotropic hypogonadism", Eur J Endocrinol, 174, pp.R267~R274 (2016)
- Sanlaville D, "CHARGE syndrome: an update", Eur J Hum Genet, 15, pp.389~399 (2007)
- Jongmans MC, "CHD7mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome", Clin Genet, 75, pp.65~71 (2009)
- Boehm U, "Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment", Nat Rev Endocrinol, 11, pp.547~564 (2015)
- Laitinen EM, "Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations", PLoS One, 7, pp.e39450~ (2012)
- Dwyer AA, "Transition in endocrinology: hypogonadism in adolescence", Eur J Endocrinol, 173, pp.R15~R24 (2015)